GENOVATE BIOTECHNOLOGY CO. LTD. financial statements, including revenue, expenses, profit, and loss
The total revenue of 4130 for the last quarter is 119.45 M TWD, and it's 12.85% lower compared to the previous quarter. The net income of Q4 23 is -14.32 M TWD.